Prescribing Psychotropics bridges the gap between the complexities of drug pharmacokinetics and everyday clinical practice, providing clinicians more insight into how psychiatric drugs behave (or misbehave!) once their patients take them.
As clinicians we are often faced with questions from families about the “best” program for autism intervention. While children with autism may receive a range of services including speech and language therapy, occupational therapy, and social skills help, the anchor to most programs is some form of behavioral health treatment. The latest issue of The Carlat Child Psychiatry Report includes an interview with Dr. Micheal Sandbank, who’s an assistant professor of special education at the University of Texas, Austin. Dr. Sandbank specializes in early childhood special education, and she and her colleagues published a systematic review and meta-analysis that has taken the Autism research community by storm. In this podcast, Mara and I will discuss Dr. Sandbank’s research and three main approaches to autism intervention.
This deep dive podcast breaks through the dogma of autism intervention and helps you to understand the three main branches of autism intervention and their very different mechanisms, the quality of autism research with a huge shift in our understanding of what works, and addresses such questions as how many hours are really needed for intervention?
You Might Also Enjoy...
Prescribing Psychotropics bridges the gap between the complexities of drug pharmacokinetics and everyday clinical practice, providing clinicians more insight into how psychiatric drugs behave (or misbehave!) once their patients take them.
As leaders we want to be kind while being effective, and this can be difficult. How do make sure that we do not become tired and angry but instead stay fresh and creative? Hear Zoe Kernohan Neely, Josh Feder MD & Jerri Lynn Hogg PhD in three mini videos.
Positive Development is a start-up aiming to change the culture of the current state of autism treatment so that it opens the door for evidence-based developmental approaches for autism that are much more humane.
We break down three main autism intervention approaches, and provide you with information that will help you improve on your abilities to recognize which particular autism intervention might be best for a specific patient.
It's all over the internet: a new non-stimulant medication approved by the FDA for treatment of ADHD. but is Viloxazine (Qelbree) going to be a game changer? Find out!
There's so much marketing for genetic testing, but does it really help clinical care? Listen to our interview with Dr. Aaron Besterman about how genetic tests work, and what can be reliably taken away from them.